Tuesday, June 30, 2015

BIO-key International, Inc. (BKYI) Expanding the Market Potential of its Biometric Identification Solutions

BIO-key International, Inc. (OTCQB: BKYI) is a leading provider of advanced fingerprint biometric identification solutions to commercial and government enterprises, integrators and application developers. The company’s award-winning finger identification technology is currently used in some of the world’s largest identification deployments in order to improve security, guarantee identity and reduce identity theft. BIO-key’s software-based products are optimized to deliver fast and accurate user authentication on any device, network or internet environment, giving the company a highly scalable asset to promote future growth.

In March, the company expanded upon its existing product offerings through the announcement of EcoID, a compact USB touch fingerprint reader that delivers top quality identification at an unprecedented price point. With a manufacturer’s suggested retail price that’s substantially lower than other USB touch scanners, BIO-key will look to leverage this product in order to secure a larger share of the touch fingerprint reader market.

In May, BIO-key highlighted an additional, potentially expansive application for its technology when it announced a partnership with HealthCast, Inc. to deliver innovative solutions for single sign-on (SSO) and secure two-factor authentication for electronic prescription of controlled substances (EPCS) to clients across the United States. Potential customers include leading hospitals and hospital systems, such as Rady’s Children’s Hospital in San Diego, California, the first hospital in the country to deploy an EPCS solution utilizing the company’s proprietary EpicCare EMR technology.

“We understand that the doctors and nurses appreciate innovative technology that streamlines what was once a time-consuming and less secure process,” Jim Skidmore, vice president of sales at BIO-key, stated in a news release. “We are pleased to provide our solutions with those of HealthCast to meet these needs.”

Despite a decline in revenue during the first quarter of 2015, BIO-key is in a strong position to capitalize on the wide-spread potential applications of its technology in the months to come. By focusing its sales and marketing efforts on large enterprise and government opportunities, the company will look to achieve vastly increased revenue for the remaining quarters of 2015. In May, BIO-key reported a pipeline of sales opportunities valued at $30 million with which to promote this forecast financial growth.

“We made good progress across the business during the first quarter, helping to solidify our outlook for the balance of 2015 and beyond,” Michael DePasquale, chairman and chief executive officer of BIO-key, stated. “Though our first quarter sales performance fell below last year’s level… we are on target to achieve our full year revenue guidance of five to seven million dollars and expect to demonstrate the strength of our sales effort in our second quarter performance.”

For prospective investors, BIO-key’s recent progress toward expanding the market potential of its innovative biometric technology makes the company an intriguing option to consider moving forward. As it looks to convert upon the massive potential of its sales pipeline, look for BIO-key to take steps toward increasing its share of the domestic security software industry.

For more information, visit www.bio-key.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.


Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

No comments: